Imaging of Chromophobe Renal Cell Carcinoma with 99m Tc-Sestamibi SPECT/CT: Considerations Regarding Risk Stratification and Histologic Reclassification.
Steven P RoweSalikh MurtazalievJorge D OldanBasil KaufmannAmna KhanMohammad E AllafNirmish SinglaChristian P PavlovichAngelo M De MarzoEzra BarabanMichael A GorinLilja B SolnesPublished in: Molecular imaging and biology (2024)
Based on current histopathologic classification methods, it is likely that the "false-positive" rate of uptake on renal sestamibi scans with chRCC has been over-stated. Further study is warranted to better refine the optimal utility of renal sestamibi scans for non-invasive risk stratification of indeterminate renal masses.